<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Third Harmonic Bio, a clinical-stage company developing a first-in-class, highly selective, oral KIT inhibitor for the treatment of severe allergy and inflammation, announced today the appointment of Robert Ho as Chief Financial Officer. “We are delighted to welcome Bob to the Third Harmonic team,” said Natalie Holles, Chief Executive Officer of Third Harmonic Bio. “Bob’s extensive experience in capital markets, finance operations, and strategy will bring a vi
...read full article on Business Wire
